Brief: Sprint Bioscience Starts Final Negotiations Regarding STK25-Project
Nov 15 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* STARTS FINAL NEGOTIATIONS REGARDING STK25-PROJECT
* ENTERED INTO MUTUAL AGREEMENT ON TERM SHEET FOR STK25
PROJECT
* ENTERS INTO AGREEMENT WITH PHARMACEUTICAL CO WITH FOCUS ON
DIABETES AND METABOLIC DISEASES
Source text for Eikon: ID:nWkr4sgrNs
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln